Creatine supplementation to improve the peripheral and central inflammatory profile in cerebral palsy

Clin Nutr ESPEN. 2022 Dec:52:254-256. doi: 10.1016/j.clnesp.2022.11.016. Epub 2022 Nov 24.

Abstract

This opinion paper presents a brief review on the potential use of Creatine (Cr) to improve the inflammatory profile in individuals with Cerebral Palsy (CP). CP is a condition that causes muscle atrophy followed by reduced strength and altered muscle tone. The prevalence of chronic diseases is higher in people with CP due to this, which are often associated with peripheral inflammation, but there are no studies that have evaluated central inflammation in this condition. Nevertheless, the anti-inflammatory action of Cr has already been observed in different types of studies. Thus, the use of experimental models of CP to evaluate the expression of the inflammatory markers, especially in the brain, as well as approaches to reduce the impairments already observed becomes essential. Results obtained in these preclinical studies may contribute to the quality of therapeutic strategies offered to children suffering from CP, the most common cause of chronic motor disability in childhood.

Keywords: Brain damage; Creatine; Developmental disabilities; Inflammation; Natural compounds; Neuroprotection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cerebral Palsy* / complications
  • Child
  • Creatine / therapeutic use
  • Dietary Supplements
  • Disabled Persons*
  • Humans
  • Inflammation / complications
  • Inflammation / drug therapy
  • Motor Disorders* / complications

Substances

  • Creatine